There is also ample “fallow space” in order to adapt to future needs of the industry.
Two areas NIBRT is looking into are antibody-drug conjugates (ADCs) and the evolving nature of single-use systems, with the Centre hosting industry events next month.
Thermo Fisher Scientific - Biosciences | 22-Mar-2023
| Technical / White Paper
Nucleoside triphosphates (NTPs) are vital components of emerging RNA therapeutics and vaccines. Controlling impurities that may be present in them while...
Deliver safe and stable products to your patients with the help of Catalent Biologics' Limoges, France site, a European Center of Excellence for early-phase...
